Business Description
Founded in 2003 and headquartered in Seoul, South Korea, Penetrium Bioscience Inc. is a contract research organization that supports drug and medical device development across a range of specialized services. The company helps clients navigate the clinical development process, covering areas such as data management, biostatistics, medical writing, and regulatory submissions. It also manages drug safety monitoring and quality assurance on behalf of its clients. Previously operating under the name Hyundai ADM Bio Inc., the company adopted its current name in March 2026.
